|
2007 Conference Publication Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patientsMollee, Peter, Hourigan, Matthew, Johnson, David, Jones, Mark, Isbel, Nikki, Hawley, Carmel, Marlton, Paula, Gandhi, Maher, Campbell, Scott and Gill, Devinder (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA USA, 8-11 December 2007. Washington, DC USA: American Society of Hematology. |
|
2007 Journal Article Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disordersGandhi, M., Wilkie, G. M., Dua, U., Mollee, P., Grimmett, K., Williams, T., Whitaker, N., Gill, D. and Crawford, D. (2007). Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders. American Journal of Transplantation, 7 (5), 1293-1299. doi: 10.1111/j.1600-6143.2007.01796.x |
|
2007 Journal Article Epstein-Barr virus T-cell immunity despite rituximabNehring, Angela K., Dua, Ujjwal, Mollee, Peter, Gill, Devinder, Grimmett, Karen, Khanna, Rajiv, Moss, Denis and Gandhi, Maher K. (2007). Epstein-Barr virus T-cell immunity despite rituximab. British Journal of Haematology, 136 (4), 628-632. doi: 10.1111/j.1365-2141.2006.06482.x |
|
2007 Journal Article Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphomaGandhi, Maher K., Moll, Guido, Smith, Corey, Dua, Ujjwal, Lambley, Eleanore, Ramuz, Olivier, Gill, Devinder, Marlton, Paula, Seymour, John F. and Khanna, Rajiv (2007). Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphoma. Blood, 110 (4), 1326-1329. doi: 10.1182/blood-2007-01-066100 |
|
2007 Journal Article Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trialHaque, T., Wilkie, G., Jones, M., Higgins, C., Urquhart, G., Wingate, P., Burns, D., McAulay, K., Turner, M., Bellamy, C., Amlot, P., Kelly, D., MacGilchrist, A., Gandhi, M., Swerdlow A. and Crawford, D. (2007). Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood, 110 (4), 1123-1131. doi: 10.1182/blood-2006-12-063008 |
|
2007 Conference Publication Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant PatientsHourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. American Transplant Congress 2007, USA, 5-9 May 2007. UK: Wiley-Blackwell Publising Ltd.. doi: 10.1111/j.1600-6143.2007.01811.x |
|
2007 Journal Article The use of T-cell directed cellular therapies in AustraliaMoss, D.J., Khanna, R. and Gandhi, M. (2007). The use of T-cell directed cellular therapies in Australia. Cytotherapy, 9 (3), 222-224. doi: 10.1080/14653240701320288 |
|
2007 Conference Publication Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patientsHourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. American Transplant Congress, San Francisco, CA, USA, 5-9 May 2007. Oxford, England: Wiley-Blackwell. doi: 10.1111/j.1600-6143.2007.01811.x |
|
2007 Journal Article The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantationHourigan, M. J., Mollee, P. N., Gill, D. S., Doecke, J., Norris, D., Johnson, D. W. and Gandhi, M. K.. (2007). The International Prognostic Index: the “gold-standard” in post-transplant lymphoproliferative disorders after renal transplantation. American Journal of Transplantation, 7, 399-399. |
|
2006 Journal Article Functional reversion of antigen-specific CD8(+) T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitopeSmith, Corey, Cooper, Leanne, Burgess, Melinda, Rist, Michael, Webb, Natasha, Lambley, Eleanore, Tellam, Judy, Marlton, Paula, Seymour, John F., Gandhi, Maher and Khanna, Rajiv (2006). Functional reversion of antigen-specific CD8(+) T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope. Journal of Immunology, 177 (7), 4897-4906. doi: 10.4049/jimmunol.177.7.4897 |
|
2006 Journal Article Epstein-Barr virus and advanced chronic lymphocytic leukemia: innocent until proven guilty? Commentary on: Tsimberidou et al. Epstein-Barr virus in patients with chronic lymphocytic leukemia: A pilot study. Leuk Lymphoma 2006; 47 : 827-836Gandhi, M and Khanna, R (2006). Epstein-Barr virus and advanced chronic lymphocytic leukemia: innocent until proven guilty? Commentary on: Tsimberidou et al. Epstein-Barr virus in patients with chronic lymphocytic leukemia: A pilot study. Leuk Lymphoma 2006; 47 : 827-836. Leukemia & Lymphoma, 47 (5), 779-780. doi: 10.1080/10428190600580973 |
|
2006 Journal Article Epstein-Barr virus and advanced chronic lymphocytic leukemia: innocent until proven guilty?Gandhi, Maher and Khanna, Rajiv (2006). Epstein-Barr virus and advanced chronic lymphocytic leukemia: innocent until proven guilty?. Leukemia and Lymphoma, 47 (5), 779-780. doi: 10.1080/10428190600580973 |
|
2006 Journal Article Epstein-Barr virus-associated lymphomasGandhi, M. K. (2006). Epstein-Barr virus-associated lymphomas. Expert Review of Anti-Infective Therapy, 4 (1), 77-89. doi: 10.1586/14737140.4.1.77 |
|
2006 Journal Article Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8(+) T-cell function in Hodgkin lymphoma patientsGandhi, M. K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J. and Khanna, R. (2006). Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8(+) T-cell function in Hodgkin lymphoma patients. Blood, 108 (7), 2280-2289. doi: 10.1182/blood-2006-04-015164 |
|
2006 Journal Article Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphomaGandhi, M. K., Lambley, E., Burrows, J., Dua, U., Elliott, S., Shaw, P. J., Prince, H. M., Wolf, M., Clarke, K., Underhill, C., Mills, T., Mollee, P., Gill, D., Marlton, P., Seymour, J. F. and Khanna, R. (2006). Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clinical Cancer Research, 12 (2), 460-464. doi: 10.1158/1078-0432.CCR-05-2008 |
|
2006 Journal Article Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphomaWilson, W. M., Dua, U., Grigg, A. P. and Gandhi, M. K. (2006). Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphoma. Leukemia & Lymphoma, 47 (5), 871-876. doi: 10.1080/10428190600649562 |
|
2005 Journal Article Viruses and lymphomaGandhi, Maher K. and Khanna, Rajiv (2005). Viruses and lymphoma. Pathology, 37 (6), 420-433. doi: 10.1080/003130200500368303 |
|
2005 Journal Article Regulation of clinical researchGandhi, Maher K. (2005). Regulation of clinical research. Clinical Medicine, 5 (3), 299-299. doi: 10.7861/clinmedicine.5-3-299 |
|
2005 Journal Article Follicular lymphoma: Time for a re-think?Gandhi, Maher K. and Marcus, Robert E. (2005). Follicular lymphoma: Time for a re-think?. Blood Reviews, 19 (3), 165-178. doi: 10.1016/j.blre.2004.09.001 |
|
2005 Journal Article Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioningCohen, J, Gandhi, M, Naik, P, Cubitt, D, Rao, K, Thaker, U, Davis, EG, Gaspar, HB, Amrolia, PJ and Veys, P (2005). Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning. British Journal of Haematology, 129 (2), 229-239. doi: 10.1111/j.1365-2141.2005.05439.x |
